V. Essebag

A. Verma, V. Essebag, J. Joza, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Clinical Predictors of Fidelis Lead Failure: Report From the Canadian Heart Rhythm Society Device Committee

J. Healey, A. Verma, A. Krahn, 2012, Circulation.

Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial Fibrillation

J. Tu, E. Rahme, H. Behlouli, 2012, Circulation.

Assessment of the cardiac patient for fitness to drive.

P. Poirier, Anil Gupta, P. Dorian, 1992, The Canadian journal of cardiology.

Temporal trends in medication use and outcomes in atrial fibrillation.

J. Tu, H. Behlouli, L. Pilote, 2013, The Canadian journal of cardiology.

Meta‐Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study

J. Healey, A. Verma, R. Kalil, 2015, Pacing and clinical electrophysiology : PACE.

Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit).

A. Demchuk, A. Skanes, K. Ramanathan, 2015, The American journal of cardiology.

Influence of Age, Gender, and AF Recurrence on Quality of Life Outcomes in a Population of New-Onset AF Patients: the FRACTAL Registry

P. Zimetbaum, T. Lavelle, M. Reynolds, 2008 .

Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines.

J. Cox, A. Krahn, D. Exner, 2017, The Canadian journal of cardiology.

Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.

J. Healey, W. Stevenson, D. Coyle, 2018, JACC. Clinical electrophysiology.

Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.

S. Connolly, C. Morillo, A. Krahn, 2018, Journal of the American College of Cardiology.

Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial

J. Healey, M. Gardner, G. Wells, 2017, Circulation. Arrhythmia and electrophysiology.

Maximizing biventricular pacing in patients with rate‐controlled atrial fibrillation using ventricular sense response

V. Essebag, A. AlTurki, M. Montemezzo, 2019, Pacing and clinical electrophysiology : PACE.

Biventricular pacing for end-stage heart failure: early experience in surgical vs. transvenous left ventricular lead placement.

D. Shum-Tim, V. Essebag, R. Atoui, 2008, Interactive cardiovascular and thoracic surgery.

Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies.

I. Porto, A. Leo, D. Birnie, 2015, European review for medical and pharmacological sciences.

Cost effectiveness of continued-warfarin versus heparin-bridging therapy during pacemaker and defibrillator surgery.

J. Healey, A. Verma, D. Coyle, 2015, Journal of the American College of Cardiology.

Cardiac Arrest Arrhythmias

M. Toma, V. Essebag, J. Joza, 2014 .

Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations

J. Tu, E. Rahme, H. Behlouli, 2011, Canadian Medical Association Journal.

Association of the left common ostium with clinical outcome after pulmonary vein isolation in atrial fibrillation

R. Lopes, V. Essebag, R. Ronsoni, 2020, Indian pacing and electrophysiology journal.

Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy.

J. Healey, T. Huynh, P. Dorian, 2018, The American journal of cardiology.

Structural heart disease as the cause of syncope

V. Essebag, R. Guimaraes, T. Leiria, 2018, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

A Cost-Utility Analysis of the Syncope: Pacing or Recording in The Later Years (SPRITELY) Trial

C. Morillo, E. Spackman, M. Talajic, 2022, CJC open.

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)

J. Healey, S. Connolly, R. Sandhu, 2018, European heart journal.

Snapshot of adult invasive cardiac electrophysiology in Canada: results of the web-based registry

J. Healey, C. Morillo, A. Verma, 2014, Journal of Interventional Cardiac Electrophysiology.

Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects.

J. Healey, G. Amit, A. Krahn, 2019, American heart journal.

Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing

J. Healey, A. Krahn, M. Gardner, 2018, Circulation. Arrhythmia and electrophysiology.

Class I and Class III Antiarrhythmic Agents: Mechanisms of Action and the Problem of Proarrhythmic Activity

V. Essebag, 2020 .

Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial

J. Healey, A. Verma, J. Rouleau, 2022, Circulation.

Population-Level Sex Differences and Predictors for Treatment With Catheter Ablation in Patients With Atrial Fibrillation and Heart Failure

M. Abrahamowicz, L. Pilote, V. Essebag, 2020, CJC open.

Incidence, Predictors, and Procedural Results of Upgrade to Resynchronization Therapy: The RAFT Upgrade Substudy

J. Healey, R. Yee, D. Exner, 2015, Circulation. Arrhythmia and electrophysiology.

Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial

G. Lip, J. Douketis, J. Healey, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial

A. Verma, A. Skanes, G. Amit, 2022, Journal of Interventional Cardiac Electrophysiology.

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.

John L Sapp, George A Wells, Jean-Francois Roux, 2016, The New England journal of medicine.

Prognostic Value of Noninducibility on Outcomes of Ventricular Tachycardia Ablation: A VANISH Substudy.

I. Nault, L. Gula, S. Doucette, 2018, JACC. Clinical electrophysiology.

Mexiletine or catheter ablation after amiodarone failure in the VANISH trial

J. Healey, I. Nault, M. Gardner, 2018, Journal of cardiovascular electrophysiology.

Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.

J. Healey, W. Stevenson, D. Coyle, 2017, JACC. Clinical electrophysiology.

Canadian Registry of Electronic Device Outcomes: remote monitoring outcomes in the Abbott battery performance alert-a multicentre cohort.

R. Sandhu, A. Krahn, R. Yee, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Pacemaker or defibrillator surgery without interruption of anticoagulation.

Atul Verma, George A Wells, Vidal Essebag, 2013, The New England journal of medicine.

Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.

J. Healey, R. Sandhu, A. Verma, 2019, Circulation. Arrhythmia and electrophysiology.

Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial

J. Healey, S. Connolly, S. Hohnloser, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study.

J. Healey, A. Verma, A. Krahn, 2016, Journal of the American College of Cardiology.

Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators.

J. Healey, M. Gardner, S. Doucette, 2020, JACC. Clinical electrophysiology.

Fusion pacing in patients with right bundle branch block who undergo cardiac resynchronization therapy.

V. Essebag, J. Joza, M. Bernier, 2020, Journal of electrocardiology.

Implantation of cardiac resynchronization therapy devices using three leads by cephalic vein dissection approach

V. Essebag, R. Proietti, A. Hadjis, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Response to Letters Regarding Article, “Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial Fibrillation”

J. Tu, E. Rahme, H. Behlouli, 2013 .

Intracardiac echo-facilitated 3D electroanatomical mapping of ventricular arrhythmias from the papillary muscles: assessing the ‘fourth dimension’ during ablation

C. Dussault, V. Essebag, M. Bernier, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Long‐term outcomes of catheter ablation for atrial fibrillation: It's a matter of time

V. Essebag, M. Samuel, A. AlTurki, 2020, Journal of cardiovascular electrophysiology.

Response to the Editor:

V. Essebag, M. Sturmer, G. Becker, 2008 .

Complications Associated With Revision of Sprint Fidelis Leads: Report From the Canadian Heart Rhythm Society Device Advisory Committee

J. Healey, A. Verma, A. Krahn, 2010, Circulation.

Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of the Riata Lead Under Advisory

J. Healey, R. Sandhu, A. Verma, 2016, Circulation. Arrhythmia and electrophysiology.

Dabigatran use in elderly patients with atrial fibrillation

E. Rahme, H. Behlouli, L. Pilote, 2015, Thrombosis and Haemostasis.

Cardiac resynchronization therapy reprogramming to improve electrical synchrony in patients with existing devices.

V. Essebag, J. Joza, M. Bernier, 2019, Journal of electrocardiology.

Population‐level evaluation of complications after catheter ablation in patients with atrial fibrillation and heart failure

M. Abrahamowicz, L. Pilote, V. Essebag, 2019, Journal of cardiovascular electrophysiology.

Long‐term risk of stroke and bleeding post–atrial fibrillation ablation

A. Verma, H. Behlouli, L. Pilote, 2018, Journal of cardiovascular electrophysiology.

CHARACTERIZATION OF ARRHYTHMIA SUBSTRATE TO ABLATE PERSISTENT ATRIAL FIBRILLATION (COAST-AF): RANDOMIZED CONTROLLED TRIAL DESIGN AND RATIONALE.

A. Verma, A. Skanes, I. Nault, 2022, American heart journal.

Inappropriate Shock Despite Successful Termination of Supraventricular Tachycardia by Antitachycardia Pacing during Charging

V. Essebag, M. Bernier, 2010, Pacing and clinical electrophysiology : PACE.

Defining the pattern of initiation of monomorphic ventricular tachycardia using the beat-to-beat intervals recorded on implantable cardioverter defibrillators from the RAFT study: A computer-based algorithm.

L. Glass, A. Shrier, V. Essebag, 2018, Journal of electrocardiology.

Routine advance directive and organ donation questioning on admission to hospital.

G. Crelinsten, V. Essebag, M. Cantarovich, 2002, Annals.

Letter by Proietti et al regarding article, "Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale".

V. Essebag, G. Thanassoulis, R. Proietti, 2014, Circulation.

Right Ventricular Septal Lead Implantation: New Site, New Risks?

V. Essebag, M. Sturmer, G. Becker, 2008, Journal of cardiovascular electrophysiology.

Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design.

J. Healey, K. Ellenbogen, S. Nattel, 2019, The Canadian journal of cardiology.

Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis

J. Tu, E. Rahme, H. Behlouli, 2014, Circulation.

Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure

Michal Abrahamowicz, Robert W Platt, Vidal Essebag, 2005 .

Long-term effectiveness of catheter ablation in patients with atrial fibrillation and heart failure.

M. Abrahamowicz, L. Pilote, V. Essebag, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Prevention of venous thrombosis after electrophysiology procedures: a survey of national practice

J. Healey, R. Sandhu, A. Verma, 2018, Journal of Interventional Cardiac Electrophysiology.

Venous Thrombosis After Electrophysiology Procedures: A Systematic Review

V. Essebag, B. Burstein, Rodrigo S. Barbosa, 2017, Chest.

Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: implementation.

J. Cox, R. Yee, D. Redfearn, 2013, The Canadian journal of cardiology.

Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.

C. Morillo, A. Verma, A. Skanes, 2013, The Canadian journal of cardiology.

Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study.

C. Morillo, A. Verma, A. Skanes, 2013, JAMA internal medicine.

Clinical Predictors of Arrhythmia Recurrences Following Pulmonary Vein Antrum Isolation for Atrial Fibrillation: Predicting Arrhythmia Recurrence Post‐PVAI

A. Verma, R. Parkash, V. Essebag, 2011, Journal of cardiovascular electrophysiology.

Inducibility of Atrial Fibrillation with a Synchronized External Low Energy Shock Post‐Pulmonary Vein Isolation Predicts Recurrent Atrial Fibrillation

M. Josephson, M. Reynolds, V. Essebag, 2009, Journal of cardiovascular electrophysiology.

Randomized Pragmatic Trial of Pacemaker Versus Implantable Cardiac Monitor in Syncope and Bifascicular Block.

C. Morillo, B. Manns, M. Brignole, 2021, JACC. Clinical electrophysiology.

Air medical transport of cardiac patients.

Vidal Essebag, S. Lutchmedial, V. Essebag, 2003, Chest.

Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence (AWARE) Trial: Design and Rationale.

C. Morillo, G. Wells, P. Nery, 2022, American heart journal.

Prognostic value of pulmonary vein size in prediction of atrial fibrillation recurrence after pulmonary vein isolation: a cardiovascular magnetic resonance study

M. Josephson, W. Manning, S. Yeon, 2015, Journal of Cardiovascular Magnetic Resonance.

A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale.

C. Morillo, A. Verma, A. Skanes, 2018, American heart journal.

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.

J. Healey, A. Verma, A. Krahn, 2019, International journal of cardiology.

Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillation.

A. Verma, H. Behlouli, L. Pilote, 2015, Heart rhythm.

Implications of Frailty in Elderly Patients With Electrophysiological Conditions.

J. Afilalo, V. Mardigyan, V. Essebag, 2016, JACC. Clinical electrophysiology.

Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future

V. Essebag, V. Russo, A. AlTurki, 2019, Medicina.

Asymptomatic atrial fibrillation burden and thromboembolic events: piecing evidence together

T. Glotzer, A. Verma, C. Labos, 2016, Expert review of cardiovascular therapy.

Sustained Quality of Life Improvement Post-Cryoballoon Ablation in Patients with Paroxysmal Atrial Fibrillation: Results from the STOP-AF Post-Approval Study.

M. Mansour, B. Knight, S. Adler, 2020, Heart rhythm.

Comparison of efficacy of phased multipolar versus traditional radiofrequency ablation: A prospective, multicenter study (CAPCOST)

C. Morillo, A. Verma, G. Amit, 2019, Pacing and clinical electrophysiology : PACE.

Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials

T. Huynh, V. Essebag, A. AlTurki, 2019, BMC Cardiovascular Disorders.

Left atrial appendage isolation in atrial fibrillation catheter ablation: A meta‐analysis

J. Healey, T. Huynh, V. Essebag, 2018, Journal of arrhythmia.

The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial.

P. Kirchhof, G. Hindricks, H. Heidbuchel, 2018, American heart journal.

Assessment and Management of the Left Atrial Appendage Thrombus in Patients With Nonvalvular Atrial Fibrillation.

T. Huynh, V. Essebag, G. Thanassoulis, 2017, The Canadian journal of cardiology.

A Systematic Review on the Progression of Paroxysmal to Persistent Atrial Fibrillation: Shedding New Light on the Effects of Catheter Ablation.

J. Healey, A. Verma, S. Nattel, 2015, JACC. Clinical electrophysiology.

Trends in US Hospitalization Rates and Rhythm Control Therapies Following Publication of the AFFIRM and RACE Trials

P. Zimetbaum, M. Reynolds, V. Essebag, 2011, Journal of cardiovascular electrophysiology.

Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation.

M. Josephson, P. Zimetbaum, A. Buxton, 2007, Archives of internal medicine.

Healthcare Resource Utilization and Costs Associated with Recurrent Episodes of Atrial Fibrillation: The FRACTAL Registry

P. Zimetbaum, D. Cohen, M. Reynolds, 2007, Journal of cardiovascular electrophysiology.

Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry.

M. Josephson, D. Cannom, P. Zimetbaum, 2006, The American journal of cardiology.

Effect of Amiodarone Dose on the Risk of Permanent Pacemaker Insertion

Robert W. Platt, M. Abrahamowicz, L. Pilote, 2004, Pacing and clinical electrophysiology : PACE.

Atrial flutter and embolic risk: The relationship between atrial flutter cycle length and left atrial appendage function.

M. Miglioranza, V. Essebag, Antonio Gaudie Ley, 2019, Journal of electrocardiology.

CHA2DS2VASc Score as a Predictor of Cardiovascular Events in Ambulatory Patients without Atrial Fibrillation

V. Essebag, R. Guimaraes, T. Leiria, 2015, Pacing and clinical electrophysiology : PACE.

Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials

V. Essebag, P. Danna, A. Tzikas, 2015, Medical devices.

Warfarin Treatment and Outcomes of Patients With Atrial Fibrillation in Rural and Urban Settings.

E. Rahme, L. Pilote, M. Avgil Tsadok, 2015, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation

M. Turakhia, J. Tu, P. Ho, 2017, Heart.

Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Moderate to Severe Mitral Stenosis: A Systematic Review

V. Essebag, J. Al-Maqbali, Abdullah M Al Alawi, 2023, Cureus.

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.

A. Verma, A. Skanes, G. Amit, 2022, The New England journal of medicine.

Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon: Final Results From STOP AF Post-Approval Study.

M. Mansour, B. Knight, S. Adler, 2019, JACC. Clinical electrophysiology.

Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery

J. Healey, R. Blackwell, T. Huynh, 2020, Circulation. Arrhythmia and electrophysiology.

Management of antithrombotic therapy during cardiac implantable device surgery

D. Birnie, V. Essebag, A. AlTurki, 2016, Journal of arrhythmia.

Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation.

M. Abrahamowicz, L. Pilote, R. Ionescu-Ittu, 2012, Archives of internal medicine.

The Impact of Duration of Atrial Fibrillation Recurrences on Measures of Health‐Related Quality of Life and Symptoms

A. Verma, V. Essebag, J. Koehler, 2016, Pacing and clinical electrophysiology : PACE.

Diagnosis and management of supraventricular tachycardias

V. Essebag, L. Bibas, M. Levi, 2016, Canadian Medical Association Journal.

The use of adenosine to identify dormant conduction after accessory pathway ablation: a single center experience and literature review.

V. Essebag, M. Bernier, M. Samuel, 2019, American journal of cardiovascular disease.

Bi-directional electrical pulmonary vein isolation as an endpoint for ablation of paroxysmal atrial fibrillation

John V. Wylie, M. Josephson, A. Richardson, 2005, Journal of Interventional Cardiac Electrophysiology.

Comparative Effectiveness of Wide Antral Versus Ostial Pulmonary Vein Isolation: A Systematic Review and Meta-Analysis

A. Natale, L. Di Biase, P. Santangeli, 2014, Circulation. Arrhythmia and electrophysiology.

Management of anticoagulation around pacemaker and defibrillator surgery.

J. Healey, D. Birnie, V. Essebag, 2014, Circulation.

Relationship between quality of life and burden of recurrent atrial fibrillation following ablation: CAPCOST multicentre cohort study.

C. Morillo, A. Verma, G. Amit, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Prognostic value of atrial fibrillation inducibility after right atrial flutter ablation.

K. Filion, V. Essebag, M. Eberg, 2014, Heart rhythm.

Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey.

J. Healey, A. Verma, D. Birnie, 2014, The Canadian journal of cardiology.

Left atrial function and scar after catheter ablation of atrial fibrillation.

Warren J Manning, Dana C Peters, John V. Wylie, 2008, Heart rhythm.

The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee.

J. Healey, A. Krahn, R. Yee, 2013, Heart rhythm.

Failure rate of the Riata lead under advisory: a report from the CHRS Device Committee.

J. Healey, A. Verma, A. Krahn, 2013, Heart rhythm.

Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee.

J. Healey, A. Verma, A. Krahn, 2009, The Canadian journal of cardiology.

Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee.

J. Healey, A. Verma, A. Krahn, 2009, Heart rhythm.

Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee.

J. Healey, A. Verma, A. Krahn, 2008, Heart rhythm.

Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.

H. Behlouli, L. Pilote, M. Avgil Tsadok, 2014, The American journal of cardiology.

Canadian Registry of Electronic Device Outcomes (CREDO): The Abbott ICD Premature Battery Depletion Advisory, a Multicentre Cohort Study

R. Sandhu, A. Krahn, R. Yee, 2020, CJC open.

Therapy for ventricular arrhythmias in structural heart disease: a multifaceted challenge

V. Essebag, J. Joza, R. Proietti, 2016, The Journal of physiology.

Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness.

V. Essebag, M. Eisenberg, 2003, Cardiac electrophysiology review.

Risk Factors for Infections Involving Cardiac Implanted Electronic Devices.

S. Connolly, C. Morillo, A. Krahn, 2019, Journal of the American College of Cardiology.

Recent advances in ablation of ventricular tachycardia associated with structural heart disease: overcoming the challenges of functional and fixed barriers

V. Essebag, J. Roux, R. Proietti, 2016, Current opinion in cardiology.

In-hospital management of atrial fibrillation: the CHADS₂ score predicts increased cost.

K. Filion, L. Pilote, M. Reynolds, 2011, The Canadian journal of cardiology.

Canadian Heart Rhythm Society and Canadian Association of Radiologists Consensus Statement on Magnetic Resonance Imaging with Cardiac Implantable Electronic Devices

A. Verma, J. Leipsic, D. Exner, 2014, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

Risk Stratification of an Accessory Pathway Using Isoproterenol after Cardiac Arrest.

V. Essebag, B. Burstein, Rodrigo S. Barbosa, 2018, Journal of atrial fibrillation.

Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction.

R. Platt, L. Pilote, V. Essebag, 2003, Journal of the American College of Cardiology.

Non-vitamin K Antagonists and Cardiac Implantable Electronic Devices

V. Essebag, A. AlTurki, R. Proietti, 2021, Direct Oral Anticoagulants.

Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis.

T. Huynh, V. Essebag, A. AlTurki, 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Can Cardiac Resynchronization Therapy Improve Cognitive Function? A Systematic Review

G. Castelnuovo, G. Manzoni, V. Essebag, 2014, Pacing and clinical electrophysiology : PACE.

Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?

M. Josephson, M. Reynolds, V. Essebag, 2006, The American journal of cardiology.

Standard vs Augmented Ablation of Paroxysmal Atrial Fibrillation for Reduction of Atrial Fibrillation Recurrence: The AWARE Randomized Clinical Trial.

G. Wells, P. Nery, D. Birnie, 2023, JAMA cardiology.

A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality.

A. Verma, C. Labos, A. Natale, 2015, The Canadian journal of cardiology.

Systematic Review/Meta-analysis A Systematic Review and Meta-analysis of the Association Between Implantable Cardioverter-Defibrillator Shocks and Long-term Mortality

A. Verma, C. Labos, A. Natale, 2015 .

Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISH

J. Healey, D. Redfearn, L. Gula, 2018, Journal of cardiovascular electrophysiology.

Canadian Registry of Implantable Electronic Device Outcomes: Longer-term follow-up of the Riata lead under advisory.

J. Healey, R. Sandhu, A. Verma, 2017, Heart Rhythm.

Canadian Heart Rhythm Society and Canadian Association of Radiologists consensus statement on magnetic resonance imaging with cardiac implantable electronic devices.

A. Verma, J. Leipsic, D. Exner, 2014, The Canadian journal of cardiology.

Population-Based Evaluation of Major Adverse Events After Catheter Ablation for Atrial Fibrillation.

A. Verma, H. Behlouli, L. Pilote, 2017, JACC. Clinical electrophysiology.

Catheter ablation for the treatment of atrial fibrillation is associated with a reduction in health care resource utilization

Atul Verma, Vidal Essebag, Louise Pilote, 2017, Journal of cardiovascular electrophysiology.

Reduction in shock burden with catheter ablation versus escalated antiarrhythmic drug therapy: Insights from the VANISH trial

I. Nault, V. Essebag, M. Samuel, 2022, EP Europace.

Peri-device Implantation Anticoagulation Management: Evidence and Clinical Implications

D. Birnie, V. Essebag, M. Bernier, 2014 .

Incidence and Predictors of Intracardiac Thrombus on Pre-electrophysiological Procedure Transesophageal Echocardiography

T. Huynh, V. Essebag, G. Thanassoulis, 2019, CJC open.

Metagenomic Analysis of Tuberculosis — Current Limitations

J. Healey, D. Birnie, V. Essebag, 2013 .

Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation.

M. Josephson, P. Zimetbaum, M. Reynolds, 2005, European heart journal.

High-Power Short-Duration vs Low-Power Long-Duration Ablation for Pulmonary Vein Isolation: A Substudy of the AWARE Randomized Controlled Trial

C. Morillo, J. Champagne, P. Nery, 2023, medRxiv.

Improved Flutter Ablation Outcomes Using a 10mm-tip Ablation Catheter

V. Essebag, M. Sturmer, G. Becker, 2010, Indian pacing and electrophysiology journal.

Concealed and manifest 1:2 tachycardia and atrioventricular nodal reentrant tachycardia: manifestations of dual atrioventricular nodal physiology.

M. Josephson, P. Papageorgiou, V. Essebag, 2005, Heart rhythm.

CCS Consensus Conference 2003: Assessment of the cardiac patient for fitness to drive and fly - Executive summary

Stephen Hart, British Columbia, Nova Scotia, 2004 .

Psychological effects of implantable cardioverter defibrillator shocks. A review of study methods

A. Compare, F. Pagnini, G. Castelnuovo, 2015, Front. Psychol..

Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality.

J. Healey, S. Connolly, A. Krahn, 2023, JAMA cardiology.

Impact of Choice of Prophylaxis on the Microbiology of Cardiac Implantable Electronic Device Infections: Insights From the Prevention of Arrhythmia Device Infection Trial (PADIT)

S. Connolly, C. Morillo, A. Krahn, 2021, Open forum infectious diseases.

Charting a course for cardiac electrophysiology training in Canada: the vital role of fellows in advanced cardiovascular care.

C. Morillo, A. Baranchuk, A. Krahn, 2013, The Canadian journal of cardiology.

Abstract 13884: Comparative Effectiveness and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Evidence From Real World Practice

J. Tu, E. Rahme, L. Pilote, 2013 .

Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.

J. Healey, R. Sandhu, A. Verma, 2016, American heart journal.

Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of High-Voltage Leads.

J. Healey, A. Krahn, R. Yee, 2018, The Canadian journal of cardiology.

Position Statement / Enoncde position Canadian Heart Rhythm Society and Canadian Association of Radiologists Consensus Statement on Magnetic Resonance Imaging With Cardiac Implantable Electronic Devices

A. Verma, J. Leipsic, D. Exner, 2014 .

Position Statement Canadian Heart Rhythm Society and Canadian Association of Radiologists Consensus Statement on Magnetic Resonance Imaging With Cardiac Implantable Electronic Devices

A. Verma, J. Leipsic, D. Exner, 2014 .

Guidance for catheter ablation of ventricular arrhythmia

Mark Potse, Vidal Essebag, M. Potse, 2009, Medical & Biological Engineering & Computing.

Assessment of the cardiac patient for fitness to fly: flying subgroup executive summary.

M. Tyrrell, A. Wielgosz, F. Sestier, 2004, The Canadian journal of cardiology.

Safety of long distance aeromedical transport of the cardiac patient: a retrospective study.

S. Lutchmedial, V. Essebag, M Churchill-Smith, 2001, Aviation, space, and environmental medicine.

Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial

M. Gold, G. Filippatos, C. Leclercq, 2023, The Lancet.

Optimization of Chronic Cardiac Resynchronization Therapy Using Fusion Pacing Algorithm Improves Echocardiographic Response

V. Essebag, J. Joza, M. Bernier, 2020, CJC open.

Catheter Ablation of Atrial Fibrillation: Current and Evolving Indications.

V. Essebag, J. Joza, M. Bernier, 2020, Canadian Journal of Cardiology.

Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial Fibrillation

J. Tu, E. Rahme, H. Behlouli, 2012, Circulation.

Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials

V. Essebag, P. Danna, A. Tzikas, 2015 .

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines.

D. Gladstone, A. Verma, B. Kiaii, 2015, The Canadian journal of cardiology.

Psychological Impact of Surveillance in Patients with a Defibrillator Lead under Advisory: A Prospective Evaluation

V. Essebag, M. Sturmer, G. Becker, 2013, Pacing and clinical electrophysiology : PACE.

Simple risk stratification score for prognosis of syncope

R. Sant'anna, V. Essebag, T. Kus, 2016, Journal of Interventional Cardiac Electrophysiology.

Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy.

J. Healey, I. Nault, M. Gardner, 2023, JACC. Clinical electrophysiology.

Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial

A. Verma, A. Skanes, G. Amit, 2022, Journal of Interventional Cardiac Electrophysiology.

Therapy for ventricular arrhythmias in structural heart disease: a multifaceted challenge

V. Essebag, J. Joza, R. Proietti, 2016, The Journal of physiology.

Psychological Impact of Surveillance in Patients with a Defibrillator Lead under Advisory: A Prospective Evaluation

V. Essebag, M. Sturmer, G. Becker, 2013, Pacing and clinical electrophysiology : PACE.

Diagnosis and management of supraventricular tachycardias

V. Essebag, L. Bibas, M. Levi, 2016, Canadian Medical Association Journal.

Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.

S. Connolly, C. Morillo, A. Krahn, 2018, Journal of the American College of Cardiology.

Post-operative pain following cardiac implantable electronic device implantation: insights from the BRUISE CONTROL trials.

J. Healey, R. Sandhu, A. Verma, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation (DISCERN AF)

A. Skanes, D. Birnie, J. Sapp, 2016 .

Correction.

S. Connolly, C. Morillo, A. Krahn, 2020, Journal of the American College of Cardiology.

Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial.

L. Gula, J. Sapp, R. Parkash, 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Biventricular pacing for end-stage heart failure: early experience in surgical vs. transvenous left ventricular lead placement.

D. Shum-Tim, V. Essebag, R. Atoui, 2008, Interactive cardiovascular and thoracic surgery.